Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Health Sciences profile

Professor Sarah Young

PositionProfessor
DepartmentDepartment of Pathology (DSM)
QualificationsBSc(Hons) PhD
Research summaryImmune therapies for disease

Research

Sarah gained her PhD in Immunology in 2000 and subsequently worked for the Imperial Cancer Research Fund and Cancer Research UK, before returning to New Zealand.

Sarah's research focuses on immune therapies for cancer and implementing the best strategy for activating anti-tumour immune responses in the host. The therapies investigated include vaccines, such as a virus-like particle, adenovirus and a bacterial ghost, and T cell-based therapies. All therapies aim to activate the Th1 arm of the immune response and projects are designed around this.

We have a range of projects associated with our vaccines such as determining how dendritic cells take up and process our vaccines through to the vaccines' ability to activate T cells and induce a memory response. We also have projects focussed on T cell adoptive therapy for tumours, in particular CD4 T cell therapy.

These research projects use a variety of immunological techniques, such as flow cytometry, bead arrays, cell sorting, and confocal microscopy.

Aside from research, Sarah is also a member of the Lotteries Health Assessing Committee and is the deputy convener of the O-Zone group at the University of Otago (a group of early-to-mid-career researchers who have been awarded Early Career Awards for Distinction in Research).

In 2008 she was also awarded the prestigious Sir Charles Hercus Fellowship by the Health Research Council.

Publications

Mainini, F., Larsen, D. S., Webster, G. A., Young, S. L., & Eccles, M. R. (2018). MIS416 as a siRNA delivery system with the ability to target antigen-presenting cells [Brief communication]. Nucleic Acid Therapeutics. Advance online publication. doi: 10.1089/nat.2017.0695

Li, K., Donaldson, B., Young, V., Ward, V., Jackson, C., Baird, M., & Young, S. (2017). Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes. Clinical & Translational Immunology, 6(10), e160. doi: 10.1038/cti.2017.37

Donaldson, B., Al-Barwani, F., Pelham, S. J., Young, K., Ward, V. K., & Young, S. L. (2017). Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer. Journal of ImmunoTherapy of Cancer, 5, 69. doi: 10.1186/s40425-017-0270-1

Grant, M. L., Shields, N., Neumann, S., Kramer, K., Bonato, A., Jackson, C., Baird, M. A., & Young, S. L. (2017). Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8+ T cells. Clinical & Translational Immunology, 6(7), e149. doi: 10.1038/cti.2017.28

Kramer, K., Shields, N. J., Poppe, V., Young, S. L., & Walker, G. F. (2017). Intracellular cleavable CpG oligodeoxynucleotide-antigen conjugate enhances anti-tumor immunity. Molecular Therapy, 25(1), 62-70. doi: 10.1016/j.ymthe.2016.10.001

Chapter in Book - Research

Donaldson, B., Al-Barwani, F., Young, V., Scullion, S., Ward, V., & Young, S. (2015). Virus-like particles, a versatile subunit vaccine platform. In C. Foged, T. Rades, Y. Perrie & S. Hook (Eds.), Subunit vaccine delivery. (pp. 159-180). New York: Springer. doi: 10.1007/978-1-4939-1417-3

^ Top of page

Journal - Research Article

Li, K., Donaldson, B., Young, V., Ward, V., Jackson, C., Baird, M., & Young, S. (2017). Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes. Clinical & Translational Immunology, 6(10), e160. doi: 10.1038/cti.2017.37

Kramer, K., Shields, N. J., Poppe, V., Young, S. L., & Walker, G. F. (2017). Intracellular cleavable CpG oligodeoxynucleotide-antigen conjugate enhances anti-tumor immunity. Molecular Therapy, 25(1), 62-70. doi: 10.1016/j.ymthe.2016.10.001

Grant, M. L., Shields, N., Neumann, S., Kramer, K., Bonato, A., Jackson, C., Baird, M. A., & Young, S. L. (2017). Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8+ T cells. Clinical & Translational Immunology, 6(7), e149. doi: 10.1038/cti.2017.28

Donaldson, B., Al-Barwani, F., Pelham, S. J., Young, K., Ward, V. K., & Young, S. L. (2017). Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer. Journal of ImmunoTherapy of Cancer, 5, 69. doi: 10.1186/s40425-017-0270-1

Kramer, K., Young, S. L., & Walker, G. F. (2017). Comparative study of 5′- and 3′-linked CpG–antigen conjugates for the induction of cellular immune responses. ACS Omega, 2(1), 227-235. doi: 10.1021/acsomega.6b00368

Jemon, K., Leong, C.-M., Ly, K., Young, S. L., McLellan, A. D., & Hibma, M. H. (2016). Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice. Scientific Reports, 6, 34789. doi: 10.1038/srep34789

Li, K., Baird, M., Yang, J., Jackson, C., Ronchese, F., & Young, S. (2016). Conditions for the generation of cytotoxic CD4+ Th cells that enhance CD8+ CTL-mediated tumor regression. Clinical & Translational Immunology, 5(8), e95. doi: 10.1038/cti.2016.46

Mainini, F., Larsen, D. S., Webster, G. A., Young, S. L., & Eccles, M. R. (2015). Bridging small molecules to modified bacterial microparticles using a disulphide linkage: MIS416 as a cargo delivery system. PLoS ONE, 10(12), e0145403. doi: 10.1371/journal.pone.0145403

Kim, D. W., Young, S. L., Grattan, D. R., & Jasoni, C. L. (2014). Obesity during pregnancy disrupts placental morphology, cell proliferation, and inflammation in a sex-specific manner across gestation in the mouse. Biology of Reproduction, 90(6), 130. doi: 10.1095/biolreprod.113.117259

Al-Barwani, F., Young, S. L., Baird, M. A., Larsen, D. S., & Ward, V. K. (2014). Mannosylation of virus-like particles enhances internalization by antigen presenting cells. PLoS ONE, 9(8), e104523. doi: 10.1371/journal.pone.0104523

Al Barwani, F., Donaldson, B., Pelham, S. J., Young, S. L., & Ward, V. K. (2014). Antigen delivery by virus-like particles for immunotherapeutic vaccination. Therapeutic Delivery, 5(11), 1223-1240. doi: 10.4155/TDE.14.74

Jemon, K., Young, V., Wilson, M., McKee, S., Ward, V., Baird, M., Young, S., & Hibma, M. (2013). An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy. PLoS ONE, 8(6), e66866. doi: 10.1371/journal.pone.0066866

Li, K., Peers-Adams, A., Win, S. J., Scullion, S., Wilson, M., Young, V. L., Jennings, P., Ward, V. K., Baird, M. A., & Young, S. L. (2013). Antigen incorporated in virus-like particles is delivered to specific dendritic cell subsets that induce an effective antitumor immune response in vivo. Journal of Immunotherapy, 36(1), 11-19. doi: 10.1097/CJI.0b013e3182787f5e

McKee, S. J., Young, V. L., Clow, F., Hayman, C. M., Baird, M. A., Hermans, I. F., Young, S. L., & Ward, V. K. (2012). Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses. Journal of Controlled Release, 159(3), 338-345. doi: 10.1016/j.jconrel.2012.02.015

Win, S. J., McMillan, D. G. G., Errington-Mais, F., Ward, V. K., Young, S. L., Baird, M. A., & Melcher, A. A. (2012). Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles. British Journal of Cancer, 106, 92-98. doi: 10.1038/bjc.2011.538

Tang, R., Li, K., Wilson, M., Both, G. W., Taylor, J. A., & Young, S. L. (2012). Potent antietumor immunity in mice induced by vaccination with an ovine Atadenovirus vector. Journal of Immunotherapy, 35(1), 32-41. doi: 10.1097/CJI.0b013e318238a115

Roberts, R. L., van Rij, A. M., Phillips, L. V., Young, S., McCormick, S. P. A., Merriman, T. R., & Jones, G. T. (2011). Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms. Atherosclerosis, 218(1), 123-126. doi: 10.1016/j.atherosclerosis.2011.04.043

Win, S. J., Ward, V. K., Dunbar, P. R., Young, S. L., & Baird, M. A. (2011). Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway. Immunology & Cell Biology, 89, 681-688. doi: 10.1038/icb.2010.161

Buchan, G. S., Lee, R., Wilson, M., Slobbe, L., Buddle, B. M., & Young, S. L. (2010). Strains of Mycobacterium avium differentially activate human dendritic cells. Immunology & Cell Biology, 88(1), 95-98. doi: 10.1038/icb.2009.51

Lateef, Z., Baird, M. A., Wise, L. M., Young, S., Mercer, A. A., & Fleming, S. B. (2010). The chemokine binding protein encoded by the poxvirus orf virus inhibits recruitment of dendritic cells to sites of skin inflammation and migration to peripheral lymph nodes. Cellular Microbiology, 12(5), 665-676. doi: 10.1111/j.1462-5822.2009.01425.x

Young, S. L., Slobbe, L. J., Peacey, M., Gilbert, S. C., Buddle, B. M., de Lisle, G. W., & Buchan, G. S. (2010). Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid-encoded cytokines against Mycobacterium bovis. Immunology & Cell Biology, 88(6), 651-657. doi: 10.1038/icb.2010.25

Peacey, M., Wilson, S., Perret, R., Ronchese, F., Ward, V. K., Young, V., Young, S. L., & Baird, M. A. (2008). Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response. Vaccine, 26, 5334-5337. doi: 10.1016/j.vaccine.2008.07.074

Williman, J., Young, S., Buchan, G., Slobbe, L., Wilson, M., Pang, P., … Baird, M. (2008). DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza. Vaccine, 26, 5153-5158. doi: 10.1016/j.vaccine.2008.03.084

Sherwin, C., Broadbent, R., Young, S., Worth, J., McCaffrey, F., Medlicott, N. J., & Reith, D. (2008). Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. American Journal of Perinatology, 25, 629-636. doi: 10.1055/s-0028-1090585

Sutherland, T. J. T., Cowan, J. O., Young, S., Goulding, A., Grant, A. M., Williamson, A., Brassett, K., Herbison, G. P., & Taylor, D. R. (2008). The association between obesity and asthma: Interactions between systemic and airway inflammation. American Journal of Respiratory & Critical Care Medicine, 178, 469-475. doi: 10.1164/rccm.200802-301OC

Young, S. L., Slobbe, L., Wilson, R., Buddle, B. M., de Lisle, G. W., & Buchan, G. S. (2007). Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination. Infection & Immunity, 75(6), 2833-2840.

Young, S. L., Wilson, M., Wilson, S., Beagley, K. W., Ward, V., & Baird, M. A. (2006). Transcutaneous vaccination with virus-like particles. Vaccine, 24, 5406-5412. doi: 10.1016/j.vaccine.2006.03.052

Baird, M., Wilson, R., Young, L., Williman, J., Young, S. L., Wilson, M., Slobbe, L., Lockhart, E., & Buchan, G. S. (2004). Bystander help within a polyepitope DNA vaccine improves immune responses to influenza antigens. Scandinavian Journal of Immunology, 60(4), 363-371.

Young, S. L., Buchan, G. S., Slobbe, L. J., Williman, J. A., Wilson, M., Ward, V. K., … Baird, M. A. (2004). Novel vaccine formulations to enhance type 1 immune responses. Immunology, 555-563.

Young, S. L., Murphy, M., Zhu, X. W., Harnden, P., O'Donnell, M. A., James, K., … Jackson, A. (2004). Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapy. International Journal of Cancer, 112, 653-660.

Young, S. L., Simon, M. A., Baird, M. A., Tannock, G. W., Bibiloni, R., Spencely, K., Lane, J. M., Fitzharris, P., Crane, J., Town, I., … Woodcock, A. (2004). Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clinical & Diagnostic Laboratory Immunology, 11(4), 686-690.

Mears, R., Craven, R. A., Hanrahan, S., Totty, N., Upton, C., Young, S. L., … Banks, R. E. (2004). Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics, 4, 4019-4031.

Young, S. L., O'Donnell, M., & Buchan, G. S. (2002). IL-2-secreting recombinant bacillus Calmette Guerin can overcome a Type 2 immune response and corticosteroid-induced immunosuppression to elicit a Type 1 immune response. International Immunology, 14(7), 793-800.

Young, S. L., O'Donnell, M., Lockhart, E., Buddle, B. M., Slobbe, L., Luo, Y., … Buchan, G. S. (2002). Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin. Immunology & Cell Biology, 80, 209-215.

Baird, M. A., Young, S. L., & Buchan, G. S. (2001). Improving vaccine formulation: Looking for the X factors. Modern Aspects of Immunobiology, 1(6), 256-258.

Buchan, G. S., Young, S. L., Lockhart, E., Wales, J. R., Faulkner, L., Slobbe, L., & Baird, M. A. (2000). Targeting early events in T cell activation to construct improved vaccines. Molecular Immunology, 37(9), 545-552.

^ Top of page

Journal - Research Other

Mainini, F., Larsen, D. S., Webster, G. A., Young, S. L., & Eccles, M. R. (2018). MIS416 as a siRNA delivery system with the ability to target antigen-presenting cells [Brief communication]. Nucleic Acid Therapeutics. Advance online publication. doi: 10.1089/nat.2017.0695

More publications...